Department of Medicine, Clinical Epidemiology Unit, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden,
J Gastroenterol. 2013 Dec;48(12):1324-31. doi: 10.1007/s00535-013-0757-6. Epub 2013 Feb 27.
Individuals with celiac disease (CD) are at increased risk of lymphoproliferative malignancy (LPM). We examined if a family history of LPM or any cancer influenced the risk of LPM in individuals with CD.
We identified 28,996 individuals with biopsy-verified CD (equal to villous atrophy, Marsh histopathology stage 3), of whom 616 had family history of LPM. Cox regression then estimated hazard ratios (HRs) for LPM in these 616 compared with two control groups. We also examined the risk of LPM in CD individuals with a family history of any cancer (n = 8,439).
During follow-up, 2/616 CD individuals with a family history of LPM, and 235/28,380 CD individuals without a family history of LPM developed LPM themselves. CD individuals with a family history of LPM were not at increased risk of LPM compared to general population controls (HR = 1.18; 95 % CI = 0.27-5.10), or compared to CD individuals without a family history of LPM (adjusted HR = 0.31; 95 % CI = 0.08-1.23). We found no increased risk of LPM in CD individuals with a family history of any cancer.
This study found no evidence that a family history of LPM or any cancer increases the risk of future LPM in individuals with CD. Despite the large number of study participants, this study is nevertheless limited by few positive events due to a low absolute risk of LPM even in individuals with CD.
乳糜泻(CD)患者发生淋巴增生性恶性肿瘤(LPM)的风险增加。我们研究了 LPM 家族史或任何癌症家族史是否会影响 CD 患者发生 LPM 的风险。
我们确定了 28996 名经活检证实的 CD 患者(与绒毛萎缩、Marsh 组织病理学 3 期相当),其中 616 名患者有 LPM 家族史。然后,Cox 回归估计了这 616 名患者与两组对照患者相比发生 LPM 的风险比(HR)。我们还研究了有任何癌症家族史的 CD 患者发生 LPM 的风险(n=8439)。
在随访期间,2/616 名有 LPM 家族史的 CD 患者和 235/28380 名无 LPM 家族史的 CD 患者自身发生了 LPM。与一般人群对照相比,有 LPM 家族史的 CD 患者发生 LPM 的风险没有增加(HR=1.18;95%CI=0.27-5.10),与无 LPM 家族史的 CD 患者相比(校正 HR=0.31;95%CI=0.08-1.23)也没有增加。我们没有发现有任何癌症家族史的 CD 患者发生 LPM 的风险增加。
本研究没有证据表明 LPM 家族史或任何癌症家族史会增加 CD 患者未来发生 LPM 的风险。尽管研究参与者数量众多,但由于 LPM 的绝对风险低,即使在 CD 患者中,阳性事件也很少,因此本研究仍受到限制。